Anton P Porsteinsson

Anton P Porsteinsson

UNVERIFIED PROFILE

Are you Anton P Porsteinsson?   Register this Author

Register author
Anton P Porsteinsson

Anton P Porsteinsson

Publications by authors named "Anton P Porsteinsson"

Are you Anton P Porsteinsson?   Register this Author

60Publications

1528Reads

41Profile Views

Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.

Alzheimers Dement 2019 Oct 3. Epub 2019 Oct 3.

Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2019.06.4946DOI Listing
October 2019

Attributable Cost of Dementia: Demonstrating Pitfalls of Ignoring Multiple Health Care System Utilization.

Health Serv Res 2018 12 23;53 Suppl 3:5331-5351. Epub 2018 Sep 23.

VHA Office Geriatrics & Extended Care Data Analysis Center (GECDAC), Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1475-6773.13048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235812PMC
December 2018

Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease.

Alzheimers Dement (Amst) 2018 30;10:604-614. Epub 2018 Aug 30.

Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dadm.2018.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215980PMC
August 2018

Insula and Inferior Frontal Gyrus' Activities Protect Memory Performance Against Alzheimer's Disease Pathology in Old Age.

J Alzheimers Dis 2017 ;55(2):669-678

Department of Neuroscience & The Ernest J. Del Monte Institute for Neuromedicine, University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-160715DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531269PMC
February 2018

An update on the advancements in the treatment of agitation in Alzheimer's disease.

Expert Opin Pharmacother 2017 Apr 28;18(6):611-620. Epub 2017 Mar 28.

b Department of Psychiatry and Behavioral Sciences, Division of Geriatric Psychiatry and Neuropsychiatry , Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1307340DOI Listing
April 2017

Dazed and Confused: Medical Cannabis in Alzheimer Disease.

Am J Geriatr Psychiatry 2016 11 31;24(11):1004-1006. Epub 2016 Aug 31.

Alzheimer's Disease Care, Research and Education Program, Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2016.08.015DOI Listing
November 2016

Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.

J Alzheimers Dis 2016 08;54(1):373-81

Alzheimer's Therapeutic Research Institute (ATRI), Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-151113DOI Listing
August 2016

ERP C250 shows the elderly (cognitively normal, Alzheimer's disease) store more stimuli in short-term memory than Young Adults do.

Clin Neurophysiol 2016 06 16;127(6):2423-35. Epub 2016 Mar 16.

Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, NY 14627, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinph.2016.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959798PMC
June 2016

Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.

Am J Psychiatry 2016 May 15;173(5):465-72. Epub 2016 Jan 15.

From the Department of Psychiatry and Behavioral Sciences and the Department of Neurology, Keck School of Medicine of University of Southern California, Los Angeles; the Department of Biostatistics, the Department of Epidemiology, and the Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health, Baltimore; the Division of Geriatric Psychiatry, Department of Psychiatry, New York State Psychiatric Institute and Columbia University Medical Center, New York; the Department of Psychiatry and Behavioral Sciences, Johns Hopkins Medicine, Baltimore; the Clinical Biotechnology Research Institute, Roper St. Francis Healthcare, Charleston, S.C.; the Campbell Institute, Centre for Addiction and Mental Health, and the Department of Psychiatry, University of Toronto, Toronto; the Culture and Mental Health Laboratory, University of Southern California, Los Angeles; the Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, N.Y.; the Biostatistics Consulting Center, Medical College of Wisconsin, Milwaukee; the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Department of Veterans Affairs Health Care System, Palo Alto, Calif.; and the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2015.15050648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419726PMC
May 2016

Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.

Am J Psychiatry 2016 May 1;173(5):473-80. Epub 2016 Apr 1.

From the Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore; the Johns Hopkins Bloomberg School of Public Health, Baltimore; the Alzheimer's Disease Care, Research, and Education Program, University of Rochester School of Medicine and Dentistry, Rochester, N.Y.; the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford; the Division of Geriatric Psychiatry, Department of Psychiatry, New York State Psychiatric Institute and College of Physicians and Surgeons of Columbia University, New York; the Clinical Biotechnology Research Institute, Roper St. Francis Healthcare, and the Department of Psychiatry, Ralph H. Johnson VA Medical Center, Charleston, S.C.; the Campbell Institute, Centre for Addiction and Mental Health, and the Department of Psychiatry, University of Toronto, Toronto; the Department of Psychiatry and Behavioral Sciences and the Department of Neurology, Keck School of Medicine of University of Southern California, Los Angeles; and the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2016.15020248DOI Listing
May 2016

Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment.

Am J Geriatr Psychiatry 2016 Jan 27;24(1):70-80. Epub 2015 Jun 27.

University of Rochester School of Medicine and Dentistry, Rochester, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691566PMC
January 2016

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.

Int Psychogeriatr 2015 Dec 25;27(12):2059-67. Epub 2015 Aug 25.

Psychiatry and Behavioral Sciences,Division of Geriatric Psychiatry and Neuropsychiatry,Johns Hopkins School of Medicine,Johns Hopkins Bayview Medical Center,Baltimore,Maryland,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1041610215001106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669064PMC
December 2015

Advancements in the treatment of agitation in Alzheimer's disease.

Expert Opin Pharmacother 2015 ;16(11):1649-56

University of Rochester, Department of Brain and Cognitive Sciences and Center for Visual Science , 435 East Henrietta Road, Rochester, NY 14620 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1059422DOI Listing
November 2015

Role of citalopram in the treatment of agitation in Alzheimer's disease.

Neurodegener Dis Manag 2014 ;4(5):345-9

University of Rochester School of Medicine & Dentistry Alzheimer's Disease Care, Research & Education Program (AD-CARE), 435 East Henrietta Road, Rochester, NY 14620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt.14.35DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262920PMC
July 2015

Neuropsychiatric symptoms in dementia: a cause or consequence?

Am J Psychiatry 2015 May;172(5):410-1

From the Alzheimer's Disease Care, Research and Education Program (AD-CARE), Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, N.Y.; and the Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, N.Y.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2015.15030277DOI Listing
May 2015

Can antidepressant medication relieve agitation in Alzheimer's disease?

Expert Rev Neurother 2014 Sep;14(9):969-71

University of Rochester School of Medicine and Dentistry, 435 East Henrietta Road, Rochester, NY14620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737175.2014.947964DOI Listing
September 2014

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

N Engl J Med 2014 Jan;370(4):322-33

From Butler Hospital, Providence, RI (S.S.); Brigham and Women's Hospital, Boston (R.S.); University College London, Institute of Neurology, London (N.C.F.); University of Göteborg, Sahlgrenska University Hospital, Mölndal, Sweden (K.B.); University of Pittsburgh, Pittsburgh (W.K.); Veterans Affairs Medical Center, Seattle (M.R.); Cleo Roberts Center for Clinical Research/Sun Health Research Institute, Sun City, AZ (M.S.); Columbia University (L.S.H.) and New York University Langone Medical Center (S.F.), New York; University of Rochester School of Medicine and Dentistry, Rochester, NY (A.P.P.); Janssen Alzheimer Immunotherapy Research and Development, South San Francisco, CA (M.R., N.K., B.N., V.G., M.M., D.W., Y.L., I.C.T., E.L., E.Y., H.R.B.); Janssen Research and Development, Titusville, NJ (J.L.); Global R&D Partners and the University of California, San Diego - both in San Diego (M.G.); and Pfizer, Collegeville, PA (R.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1304839DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159618PMC
January 2014

Depression and risk of dementia: exploring the interface.

J Clin Psychiatry 2013 Dec;74(12):1262-3

University of Rochester School of Medicine, 435 East Henrietta Rd, Rochester, NY 14620

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.13com08787DOI Listing
December 2013

C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease.

J Alzheimers Dis 2013 ;33(1):55-68

Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, NY 14627, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-2012-120646DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576817PMC
September 2013

The law of diminishing intent: getting excited about apathy.

J Clin Psychiatry 2013 Aug;74(8):817-8

435 East Henrietta Rd, Rochester, NY 14620

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.13com08574DOI Listing
August 2013

Novel therapeutics in Alzheimer's disease.

Int J Alzheimers Dis 2012 26;2012:207969. Epub 2012 Mar 26.

Banner Sun Health Research Institute, 10515 W. Santa Fe Dr, Sun City, AZ 85351, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/207969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320000PMC
August 2012

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

Authors:
Trygve E Bakken J Cooper Roddey Srdjan Djurovic Natacha Akshoomoff David G Amaral Cinnamon S Bloss B J Casey Linda Chang Thomas M Ernst Jeffrey R Gruen Terry L Jernigan Walter E Kaufmann Tal Kenet David N Kennedy Joshua M Kuperman Sarah S Murray Elizabeth R Sowell Lars M Rimol Morten Mattingsdal Ingrid Melle Ingrid Agartz Ole A Andreassen Nicholas J Schork Anders M Dale Michael Weiner Paul Aisen Ronald Petersen Clifford R Jack William Jagust John Q Trojanowki Arthur W Toga Laurel Beckett Robert C Green Andrew J Saykin John Morris Enchi Liu Tom Montine Anthony Gamst Ronald G Thomas Michael Donohue Sarah Walter Devon Gessert Tamie Sather Danielle Harvey John Kornak Anders Dale Matthew Bernstein Joel Felmlee Nick Fox Paul Thompson Norbert Schuff Gene Alexander Charles DeCarli Dan Bandy Robert A Koeppe Norm Foster Eric M Reiman Kewei Chen Chet Mathis Nigel J Cairns Lisa Taylor-Reinwald J Q Trojanowki Les Shaw Virginia M Y Lee Magdalena Korecka Karen Crawford Scott Neu Tatiana M Foroud Steven Potkin Li Shen Zaven Kachaturian Richard Frank Peter J Snyder Susan Molchan Jeffrey Kaye Joseph Quinn Betty Lind Sara Dolen Lon S Schneider Sonia Pawluczyk Bryan M Spann James Brewer Helen Vanderswag Judith L Heidebrink Joanne L Lord Kris Johnson Rachelle S Doody Javier Villanueva-Meyer Munir Chowdhury Yaakov Stern Lawrence S Honig Karen L Bell John C Morris Beau Ances Maria Carroll Sue Leon Mark A Mintun Stacy Schneider Daniel Marson Randall Griffith David Clark Hillel Grossman Effie Mitsis Aliza Romirowsky Leyla deToledo-Morrell Raj C Shah Ranjan Duara Daniel Varon Peggy Roberts Marilyn Albert Chiadi Onyike Stephanie Kielb Henry Rusinek Mony J de Leon Lidia Glodzik Susan De Santi P Murali Doraiswamy Jeffrey R Petrella R Edward Coleman Steven E Arnold Jason H Karlawish David Wolk Charles D Smith Greg Jicha Peter Hardy Oscar L Lopez MaryAnn Oakley Donna M Simpson Anton P Porsteinsson Bonnie S Goldstein Kim Martin Kelly M Makino M Saleem Ismail Connie Brand Ruth A Mulnard Gaby Thai Catherine Mc-Adams-Ortiz Kyle Womack Dana Mathews Mary Quiceno Ramon Diaz-Arrastia Richard King Myron Weiner Kristen Martin-Cook Michael DeVous Allan I Levey James J Lah Janet S Cellar Jeffrey M Burns Heather S Anderson Russell H Swerdlow Liana Apostolova Po H Lu George Bartzokis Daniel H S Silverman Neill R Graff-Radford Francine Parfitt Heather Johnson Martin R Farlow Ann Marie Hake Brandy R Matthews Scott Herring Christopher H van Dyck Richard E Carson Martha G MacAvoy Howard Chertkow Howard Bergman Chris Hosein Sandra Black Bojana Stefanovic Curtis Caldwell Ging-Yuek Robin Hsiung Howard Feldman Benita Mudge Michele Assaly Andrew Kertesz John Rogers Dick Trost Charles Bernick Donna Munic Diana Kerwin Marek-Marsel Mesulam Kristina Lipowski Chuang-Kuo Wu Nancy Johnson Carl Sadowsky Walter Martinez Teresa Villena Raymond Scott Turner Kathleen Johnson Brigid Reynolds Reisa A Sperling Keith A Johnson Gad Marshall Meghan Frey Jerome Yesavage Joy L Taylor Barton Lane Allyson Rosen Jared Tinklenberg Marwan Sabbagh Christine Belden Sandra Jacobson Neil Kowall Ronald Killiany Andrew E Budson Alexander Norbash Patricia Lynn Johnson Thomas O Obisesan Saba Wolday Salome K Bwayo Alan Lerner Leon Hudson Paula Ogrocki Evan Fletcher Owen Carmichael John Olichney Smita Kittur Michael Borrie T-Y Lee Rob Bartha Sterling Johnson Sanjay Asthana Cynthia M Carlsson Steven G Potkin Adrian Preda Dana Nguyen Pierre Tariot Adam Fleisher Stephanie Reeder Vernice Bates Horacio Capote Michelle Rainka Douglas W Scharre Maria Kataki Earl A Zimmerman Dzintra Celmins Alice D Brown Godfrey D Pearlson Karen Blank Karen Anderson Robert B Santulli Eben S Schwartz Kaycee M Sink Jeff D Williamson Pradeep Garg Franklin Watkins Brian R Ott Henry Querfurth Geoffrey Tremont Stephen Salloway Paul Malloy Stephen Correia Howard J Rosen Bruce L Miller Jacobo Mintzer Crystal Flynn Longmire Kenneth Spicer Elizabether Finger Irina Rachinsky Dick Drost Terry Jernigan Connor McCabe Ellen Grant Thomas Ernst Josh Kuperman Yoon Chung Sarah Murray Cinnamon Bloss Burcu Darst Lexi Pritchett Ashley Saito David Amaral Mishaela DiNino Bella Eyngorina Elizabeth Sowell Suzanne Houston Lindsay Soderberg Walter Kaufmann Peter van Zijl Hilda Rizzo-Busack Mohsin Javid Natasha Mehta Erika Ruberry Alisa Powers Bruce Rosen Nitzah Gebhard Holly Manigan Jean Frazier David Kennedy Lauren Yakutis Michael Hill Jeffrey Gruen Joan Bosson-Heenan Heatherly Carlson

Proc Natl Acad Sci U S A 2012 Mar 16;109(10):3985-90. Epub 2012 Feb 16.

Medical Scientist Training Program, University of California at San Diego, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1105829109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309762PMC
March 2012

Depression in older adults: is there another reason to worry?

J Clin Psychiatry 2012 Jan;73(1):113-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.11com07390DOI Listing
January 2012

Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses.

J Clin Exp Neuropsychol 2010 Oct;32(8):793-808

Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627-0270, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13803390903540315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896992PMC
October 2010

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Am J Geriatr Psychiatry 2010 Apr;18(4):332-40

Section of Geriatric Psychiatry, University of Pennsylvania and Mental Illness Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JGP.0b013e3181cc0333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849739PMC
April 2010

Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.

Biol Psychiatry 2010 Mar 9;67(6):505-12. Epub 2009 Apr 9.

Department of Psychiatry, State University of New York Upstate Medical University, Syracuse, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2009.02.013DOI Listing
March 2010

Sertraline for the treatment of depression in Alzheimer disease.

Am J Geriatr Psychiatry 2010 Feb;18(2):136-45

Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JGP.0b013e3181c796ebDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842121PMC
February 2010

Depression predicts cognitive disorders in older primary care patients.

J Clin Psychiatry 2010 Jan;71(1):74-9

Department of Psychiatry, Box Psych, University of Rochester Medical Center, 300 Crittenden Blvd, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.08m04724gryDOI Listing
January 2010

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.

Curr Alzheimer Res 2008 Feb;5(1):83-9

Alzheimer's Disease Care, Research and Education Program, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156720508783884576DOI Listing
February 2008

Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly.

Drugs Aging 2006 ;23(11):877-86

Department of Psychiatry, University of Rochester Medical Center, Monroe Community Hospital, Rochester, New York 14620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00002512-200623110-00003DOI Listing
March 2007

Memantine in the treatment of mild-to-moderate Alzheimer's disease.

Expert Opin Pharmacother 2007 Feb;8(2):203-14

University of Rochester School of Medicine, Alzheimer's Disease Care Research and Education Program (AD-CARE), Monroe Community Hospital, 435 East Henrietta Road, Rochester, NY 14620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.8.2.203DOI Listing
February 2007

Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'.

Int J Geriatr Psychiatry 2005 Feb;20(2):119-27

Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gps.1261DOI Listing
February 2005

Valproate therapy for agitation in dementia: open-label extension of a double-blind trial.

Am J Geriatr Psychiatry 2003 Jul-Aug;11(4):434-40

Department of Psychiatry, Program in Neurobehavioral Therapeutics, University of Rochester Medical Center and Monroe Community Hospital, tochester, NY 14620, USA.

View Article

Download full-text PDF

Source
November 2003

Choosing treatment for Alzheimer's patients and their caregivers.

Geriatrics 2003 Aug;58 Suppl 1:3-18, 23; quiz 19-22

View Article

Download full-text PDF

Source
August 2003